SOLVATOS DE FLUVASTATINA SODICA AND ITS USE AS INTERMEDIATE IN OBTAINING FLUVASTATINA SODICA AMORFA.
ES2310121A1
NEW TELITHROMYCIN SYNTHESIS PROCESS.
ES2306590A1
CRYSTALLINE FORMS I AND II OF TELITHROMYCIN.
ES2289945A1
PROCEDURE FOR OBTAINING TWO ADVANCED INTERMEDIATES AND ITS USE FOR OBTAINING ATORVASTATIN CALCICA AMORFA.
ES2270722A1
PROCEDURE FOR OBTAINING ATORVASTATIN CALCICA AMORFA.
ES2265781A1
PROCEDURE FOR OBTAINING AMLODIPINE BESYLATE.
ES2261090A1
PROCEDURE FOR OBTAINING DERIVATIVES OF ERYTHROMYCIN A AND COMPOUNDS OBTAINED.
ES2263370A1
ATORVASTATINA CALCICA STABILIZED AMORFA AND PROCEDURE FOR OBTAINING IT.
ES2254028A1
PROCEDURE FOR OBTAINING PRAVASTATIN SODIUM PURIFIED.
ES2245596A1
Production of terbinaphin hydrochlorate (TH) comprises reaction of chlorinated and methylamine derivatives with reflux of isopropanol increasing performance
ES2239543A1
Production of an HMG-CoA reductase inhibitor comprises lactonising and e.g. acylation with controlled protection yielding high priority product
ES2239533A1
PROCEDURE FOR OBTAINING COMPACTINE.
ES2221807A1
A PROCEDURE FOR OBTAINING CLARITROMYCIN.
ES2208110A1
CRYSTAL FORMS OF FUSIDIC ACID AND PROCEDURES FOR OBTAINING IT.
ES2204331A1
PROCEDURE FOR OBTAINING FUSIDIC ACID FROM A FERMENTATION BRASS.
ES2204285A1
PROCEDURE FOR THE INSULATION AND PURIFICATION OF LOVASTATIN.
ES2184632A1
A PROCEDURE FOR OBTAINING CIS-1-PROPENYLPHOSPHONATE FROM DITERC-BUTILO.
ES2195727A1
A PROCEDURE FOR OBTAINING CLARITROMYCIN.
ES2179756A1
PROCEDURE FOR OBTAINING AZAERITHROMYCIN.
ES2162764A1
Polymorphic form of azithromycin dihydrate, and its deobtention procedure.